About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Eurasian Hematology-Oncology Group
http://www.ehog.net/
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Videos
8th Eurasian Hematology Oncology Summit
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Palliative & Supportive Care
COVID-19
Basic Science
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Lung
Business
7th Eurasian Hematology Oncology Summit
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Xth Eurasian Hematology-Oncology Congress
Breast
Lung
Hematologic Oncology
Gastrointestinal
Genitourinary
General Oncology
Sarcoma
Skin
Head & Neck
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassemia and Sickle Cell Disease Compared to MUD and Haploidentical HSCT?
By
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
FEATURING
Selim Corbacioglu
By
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
FEATURING
Selim Corbacioglu
38 views
January 18, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Benign Hematology
27:49
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Haploidentical Transplant in Developing Countries: Challenges, Moder…
Feat.
G. Karasu
23:18
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassem…
Feat.
S. Corbacioglu
12:45
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Anti-T Cell pAbs for GVHD Prevention: Does the Addition of ATLG Graf…
Feat.
F. Bonifazi
21:57
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Bone Marrow Failure: Aplastic Anemias, Telomere Diseases, GATA2 Defi…
Feat.
R. Calado
14:49
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Infections in Immunocompromised Patients: Immunodeficiencies in Bone…
Feat.
M. Nucci
19:30
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Paroxysmal Nocturnal Hemoglobinuria: Epidemiology, Classification, R…
Feat.
H. Hamed
03:38
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
2 y/o With Ecchymoses, Hepatosplenomegaly and Cervical Lymphadenopat…
Feat.
C. Coskun
14:22
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
ASFA Guidelines on the Use of Therapeutic Apheresis: What Does the G…
Feat.
N. Dunbar
19:17
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Managing Late Complications in Beta Thalassemia: Thrombotic Disease,…
Feat.
V. Huseynov
23:20
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Sickle Cell Disease: Pathogenesis, When to Recommend MSD-SCT, Antico…
Feat.
S. Alkindi
23:55
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Hemophilia Treatment in Developing Countries: What Are the Principle…
Feat.
B. Antmen
17:36
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
ITP Updates: Which Immune Suppressants Should We Use? What Is the Ef…
Feat.
D. Provan
